TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. HUBS
3. SPY
4. NUE
5. AAPL
6. AZN
7. TRMD
8. RARE
9. RTB
10. INTU

Go back to TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance
TG THERAP (NASDAQ: TGTX) Delayed: 56.47 --0 (-0%)
Previous Close $56.47    52 Week High $14.87 
Open $56.47    52 Week Low $4.90 
Day High $56.47    P/E N/A 
Day Low $56.47    EPS $-0.67 
Volume 3,293